1 – 2 of 2
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Rate and risk factors for thromboembolism and major bleeding in adults with congenital heart disease taking vitamin K antagonist therapy
(
- Contribution to journal › Article
- 2021
-
Mark
Quality and predictors of oral anticoagulation therapy with vitamin K antagonists in adult congenital heart disease : TTR and INR variability
(
- Contribution to journal › Letter